265 related articles for article (PubMed ID: 33438363)
1. Diabetic eye disease: A review of screening and management recommendations.
Gale MJ; Scruggs BA; Flaxel CJ
Clin Exp Ophthalmol; 2021 Mar; 49(2):128-145. PubMed ID: 33438363
[TBL] [Abstract][Full Text] [Related]
2. Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease.
Gale R; Scanlon PH; Evans M; Ghanchi F; Yang Y; Silvestri G; Freeman M; Maisey A; Napier J
Eye (Lond); 2017 May; 31(S1):S1-S20. PubMed ID: 28490797
[TBL] [Abstract][Full Text] [Related]
3. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
Solaiman KA; Diab MM; Dabour SA
Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and diabetic macular edema.
Lally DR; Shah CP; Heier JS
Surv Ophthalmol; 2016; 61(6):759-768. PubMed ID: 27045225
[TBL] [Abstract][Full Text] [Related]
5. A multimodal approach to diabetic macular edema.
Au A; Singh RP
J Diabetes Complications; 2016 Apr; 30(3):545-53. PubMed ID: 26853628
[TBL] [Abstract][Full Text] [Related]
6. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
Mukkamala L; Bhagat N; Zarbin MA
Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
[TBL] [Abstract][Full Text] [Related]
7. Current intravitreal pharmacologic therapies for diabetic macular edema.
Colucciello M
Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.
Arevalo JF; Lasave AF; Wu L; Diaz-Llopis M; Gallego-Pinazo R; Alezzandrini AA; Berrocal MH;
Retina; 2013 Feb; 33(2):403-13. PubMed ID: 23222389
[TBL] [Abstract][Full Text] [Related]
9. Vascular Endothelial Growth Factor and Diabetic Retinal Disease.
Ajlan RS; Silva PS; Sun JK
Semin Ophthalmol; 2016; 31(1-2):40-8. PubMed ID: 26959128
[TBL] [Abstract][Full Text] [Related]
10. Laser Therapy in the Treatment of Diabetic Retinopathy and Diabetic Macular Edema.
Everett LA; Paulus YM
Curr Diab Rep; 2021 Sep; 21(9):35. PubMed ID: 34487257
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of sight-threatening diabetic retinopathy].
Grauslund J
Ugeskr Laeger; 2018 Jul; 180(31):. PubMed ID: 30064622
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.
Glassman AR; Baker CW; Beaulieu WT; Bressler NM; Punjabi OS; Stockdale CR; Wykoff CC; Jampol LM; Sun JK;
JAMA Ophthalmol; 2020 Apr; 138(4):341-349. PubMed ID: 32077907
[TBL] [Abstract][Full Text] [Related]
13. The Diabetic Retinopathy Clinical Research Network (DRCR.net) and Its Contributions to the Treatment of Diabetic Retinopathy.
Sun JK; Jampol LM
Ophthalmic Res; 2019; 62(4):225-230. PubMed ID: 31554001
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
Ebneter A; Wolf S; Zinkernagel MS
Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
[TBL] [Abstract][Full Text] [Related]
15. Diabetic retinopathy: intravitreal vascular endothelial growth factor inhibitors for diabetic macular oedema.
Mohamed QA; Fletcher EC; Buckle M
BMJ Clin Evid; 2016 Mar; 2016():. PubMed ID: 27031563
[TBL] [Abstract][Full Text] [Related]
16. [Eye complications in type 2 diabetes mellitus].
Bek T
Ugeskr Laeger; 2012 Sep; 174(37):2147-50. PubMed ID: 22971294
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
[TBL] [Abstract][Full Text] [Related]
18. [Anti-VEGF therapy for diabetic retinopathy].
Chekhonin ES; Fayzrakhmanov RR; Sukhanova AV; Bosov ED
Vestn Oftalmol; 2021; 137(4):136-142. PubMed ID: 34410069
[TBL] [Abstract][Full Text] [Related]
19. ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy.
Barroso RMP; Messias K; Garcia DM; Cardillo JA; Scott IU; Messias A; Jorge R
Arq Bras Oftalmol; 2020; 83(6):526-534. PubMed ID: 33470281
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injections and diabetic macular edema: actual and new therapeutic options.
Pescosolido N; Pranno F; Buomprisco G
Curr Diabetes Rev; 2013 Nov; 9(6):491-8. PubMed ID: 24160355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
